SIMIONI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.246
AS - Asia 3.002
EU - Europa 2.959
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 19
AF - Africa 13
SA - Sud America 10
Totale 33.271
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.210
CN - Cina 1.420
SG - Singapore 1.148
IT - Italia 715
FI - Finlandia 587
DE - Germania 401
SE - Svezia 385
VN - Vietnam 327
FR - Francia 272
GB - Regno Unito 228
UA - Ucraina 214
IN - India 56
IE - Irlanda 44
NL - Olanda 44
CA - Canada 26
AU - Australia 16
EU - Europa 15
CH - Svizzera 12
HK - Hong Kong 12
ES - Italia 9
JP - Giappone 8
BE - Belgio 7
EG - Egitto 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
NZ - Nuova Zelanda 6
RO - Romania 6
TW - Taiwan 5
BR - Brasile 4
NO - Norvegia 4
SA - Arabia Saudita 4
TR - Turchia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
GR - Grecia 3
HN - Honduras 3
IR - Iran 3
MX - Messico 3
PH - Filippine 3
VE - Venezuela 3
CL - Cile 2
DK - Danimarca 2
IL - Israele 2
IQ - Iraq 2
LY - Libia 2
PA - Panama 2
RS - Serbia 2
A1 - Anonimo 1
AM - Armenia 1
AT - Austria 1
BD - Bangladesh 1
BS - Bahamas 1
CO - Colombia 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
OM - Oman 1
PL - Polonia 1
PR - Porto Rico 1
PT - Portogallo 1
RU - Federazione Russa 1
SZ - Regno dello Swaziland 1
TH - Thailandia 1
TN - Tunisia 1
UG - Uganda 1
Totale 33.271
Salva come PNG Salva come JPEG
Città #
Fairfield 4.626
Woodbridge 2.971
Houston 2.065
Ann Arbor 1.994
Ashburn 1.971
Chandler 1.929
Seattle 1.649
Wilmington 1.528
Cambridge 1.499
Jacksonville 953
Singapore 896
Boardman 715
Princeton 600
San Diego 486
Beijing 383
Santa Clara 339
Medford 334
Des Moines 324
Dong Ket 322
Roxbury 250
Helsinki 248
Nanjing 219
Padova 203
Hebei 81
Shenyang 81
Nanchang 78
London 64
Norwalk 53
Milan 52
New York 49
Jiaxing 47
Jinan 43
Tianjin 40
Dublin 38
Redwood City 36
Guangzhou 33
Ogden 33
Los Angeles 32
Changsha 31
Falls Church 31
Kilburn 25
Chicago 22
Shanghai 22
Kharkiv 20
Zhengzhou 19
Lappeenranta 17
Pune 17
Bologna 16
Dallas 15
Washington 15
Indiana 14
Nürnberg 14
Borås 13
Hangzhou 13
Rome 13
Chiswick 12
Rockville 12
Hefei 11
Munich 11
Sydney 11
Dearborn 10
Amsterdam 9
Mykolayiv 9
Ningbo 9
Verona 9
Ferentino 8
Kunming 8
Las Vegas 8
Acton 7
Kingston 7
Legnaro 7
Taiyuan 7
Taizhou 7
Tappahannock 7
Genoa 6
Haikou 6
Lanzhou 6
Prescot 6
Sofia 6
Southwark 6
Altavilla Vicentina 5
Belluno 5
Esslingen am Neckar 5
Frankfurt am Main 5
Hong Kong 5
Muenster 5
Naples 5
Portland 5
Shenzhen 5
Treviso 5
Turin 5
Bari 4
Basel 4
Boston 4
Brussels 4
Council Bluffs 4
Dronten 4
Falkenstein 4
Gunzenhausen 4
Hounslow 4
Totale 27.877
Salva come PNG Salva come JPEG
Nome #
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? 196
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 194
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 177
Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients 171
Dynamics of circulating microparticles in obesity after weight loss 150
Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance 146
In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context 140
Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma - Characterization of the dysfunctional protein C Padua(3) (Protein CR-1L/propeptide) 139
Activated protein C resistance in normal and pre-eclamptic pregnancies 138
Secondary parenchymal and vascular changes after middle cerebral artery stroke in children. 134
Potential role of thrombelastography in the monitoring of acquired factor VIII inhibitor hemophilia A: report on a 78-year-old woman with life-threatening bleedings. 134
Are thromboelastometric and thromboelastographic parameters associated with mortality in septic patients? A systematic review and meta-analysis 131
Acute oppressive chest pain in a 66-year-old woman with a recent Amplatzer device closure of patent foramen ovale 129
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 128
Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role. 125
Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia 124
The Coagulative Profile of Cyanotic Children Undergoing Cardiac Surgery: The Role of Whole Blood Preoperative Thromboelastometry on Postoperative Transfusion Requirement 123
null 122
Microparticles as biomarkers of venous thromboembolic events 122
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 122
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis 120
A matrix-assisted laser desorption/ionization time-of-flight based method for screening the 1691G --> A mutation in the factor V gene 119
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 119
Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? 118
The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study 117
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms 116
Clinical Data of Neonatal Systemic Thrombosis 116
ABO blood group and the risk of post-thrombotic syndrome 116
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 115
Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. 114
Cerebral sinovenous thrombosis in children: thrombophilia and clinical outcome. 113
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells 113
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. 112
Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis. 112
Short-term exposure to high levels of air pollution as a risk factor for acute isolated pulmonary embolism. 112
Platelet factor V levels in moderate to severe congenital factor V deficiency. 111
Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism. 111
Studies on coagulation incompatibilities for xenotransplantation. 110
Cerebral sinus venous thrombosis with parenchymal infarcts in a newborn with severe haemophilia A and subdural haematomas. 110
Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease 110
Effects of glycosaminoglycans and protamine chloridrate on platelet aggregation induced by collagen and thrombin. 109
Predictors of postoperative bleeding in children undergoing cardiopulmonary bypass: A preliminary Italian study 108
New prothrombin mutation (Arg596Trp, Prothrombin Padua 2) associated with venous thromboembolism 107
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies 107
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events 106
Cell therapy for Parkinson's disease: A translational approach to assess the role of local and systemic immunosuppression 106
Effects of long-term administration of recombinant human protein C in xenografted primates. 106
The biological inertia of coumarin-induced pre-factors (so called PIVKAs) 105
Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth? 105
Clinical and laboratory characteristics of isolated lupus anticoagulants 105
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 105
Whole blood rotation thromboelastometry (ROTEM®) profiles in subjects with non-neoplastic portal vein thrombosis. 104
Hypercoagulability detected by whole blood thromboelastometry (ROTEM®) and impedance aggregometry (MULTIPLATE®) in obese patients 104
Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: A role for circulating microparticles? 104
Perioperative coagulation assessment of patients undergoing major elective orthopedic surgery 104
The molecular genetics of familial venous thrombosis 104
The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease. 103
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis. 103
Procoagulant activity in children with community acquired pneumonia, pleural effusion and empyema 102
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. 102
The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein i antibodies. A comparison with a homemade ELISA method 102
Thromboelastometry guided fibrinogen replacement therapy in cardiac surgery: a retrospective observational study 102
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference 102
Thrombotic manifestations in plasminogen deficiency and in plasminogen abnormalities. 101
Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women 101
The Risk of Cancer Progression in Women With Gynecological Malignancies and Thrombophilic Polymorphisms: A Pilot Case-Control Study. 100
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. 100
"Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. 100
COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward 99
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants 98
Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. 98
Similar hypercoagulable state and thrombosis risk in type I and type III proteinS-deficient individuals from mixed type I/III families. 98
Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation 98
Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency 98
Heterozygous protein-S deficiency: a study of a large kindred. 98
Hypercoagulability In Cirrhotic Patients With Hepatocellular Carcinoma (hcc) and Portal Vein Thrombosis (pvt) 98
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases 98
Tailored prophylaxis with rFXIII (NovoThirteen ® ) in a young girl with severe FXIII deficiency and previous cephalohaematoma 98
Factor V Leiden is associated with more distal location of deep vein thrombosis of the leg. 97
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis 97
Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity. 97
Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study 97
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 97
Naturally occurring Arg-1 to Leu mutation in human protein C (protein C Padua(3)) resulting in an abnormal propeptide processing and in a molecule with discrepant functional activities 97
Pitfalls of protein C assays in patients with activated protein C resistance 96
Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area 96
Factor VIIa-antithrombin complexes in children with ischemic stroke. 96
Predictors of Response To Anticoagulant Therapy For the Treatment of Portal Vein Thrombosis (pvt) In Cirrhosis Patients 96
Whole blood thromboelastometry profiles in women with preeclampsia 96
Patient blood management in cardiac surgery: The “Granducato algorithm” 96
Guidelines for resuscitation in the delivery room of extremely preterm infants 95
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes. 95
A new global test for the evaluation of the protein C-protein S system. 95
Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke 95
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 95
Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family 94
Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. 93
Sex-related type of venous thromboembolism in patients with and without thrombophilia. 93
The relationship between defective heparin cofactor activities and thrombotic phenomena in AT III abnormalities. 93
Cerebral sinovenous thrombosis in children: Thrombophilia and clinical outcome. 93
Totale 11.116
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.377
article - articoli 124.587
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 140
Totale 252.104
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.784 0 0 0 0 687 495 638 800 846 675 317 326
2020/20215.413 181 424 254 503 522 255 171 521 609 626 589 758
2021/20225.842 181 604 694 402 310 381 249 668 319 155 535 1.344
2022/20234.098 892 389 93 427 716 513 16 279 479 48 189 57
2023/20242.355 105 339 257 222 168 238 164 106 93 99 245 319
2024/20252.737 34 832 519 378 974 0 0 0 0 0 0 0
Totale 33.624